Pharmaceutical Aspects of Polymer-Based Delivery of Nucleic Acids 2022

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".

Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 344

Special Issue Editor

E-Mail Website
Guest Editor
Department of Chemistry and Biochemistry, National Chung Cheng University, Chiayi, Taiwan
Interests: gene delivery; non-viral strategies; polymeric carriers; and/or transfection efficiency
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The therapeutic potential using nucleic acids (DNA or RNA) has many clinical applications for the treatment of diseases. For reaching the goal, these nucleic acids require vectors with efficacy and efficiency. The use of non-viral carriers, mainly based on cationic polymers which have low or no immunogenicity and are able to transfect a great variety of cells, has received substantial attention. Moreover, these polymers possess the advantages of being versatile in structures, tunable for aims, easy to produce at a large scale with a low cost, and easy to preserve.

This Special Issue focuses on the physicochemical properties as well as the transfection potential of polymer-based nucleic acid formulations (referred as polyplexes). New approaches and different polymeric systems with chemical modifications are introduced, and how these polyplexes tackle the cellular barriers, the cytotoxicity, and low transfection efficiency for a successful expression of delivered genes are demonstrated and discussed. Finally, attention is given to the stabilization of non-viral nucleic acid formulations. In summary, articles in this issue summarize the current developments of types and components of transfection reagents for the optimization of gene delivery. This set of knowledge would benefit the progress to the development of a safe and efficient gene delivery.

Dr. Jong Yuh Cherng
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • gene delivery
  • non-viral strategies
  • polymeric carriers
  • transfection efficiency

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop